Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

NCT04530318 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Judit Pich